poisar

Stocks · News reference

TransCode Therapeutics Says Peer-Reviewed Cancers Publication Shows TTX-MC138 Produced Significant Survival Benefit In Preclinical Mouse Model Of Breast Cancer Bone Metastasis

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Transcode Therapeutics, Inc. (RNAZ)

    Filed: 2026-08-03 AccNo: 0001104659-26-089805 Size: 304 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits